Stat3 promotes metastatic progression of prostate cancer

American Journal of Pathology

Volumn 172, Issue 6, 2008, Pages 1717-1728

  Abdulghani, Junaid ^a   Gu, Lei ^a   Dagvadorj, Ayush ^a   Lutz, Jacqueline ^a   Leiby, Benjamin ^a   Bonuccelli, Gloria ^a   Lisanti, Michael P ^a   Zellweger, Tobias ^b   Alanen, Kalle ^d   Mirtti, Tuomas ^d   Visakorpi, Tapio ^e   Bubendorf, Lukas ^c   Nevalainen, Marja T ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b St Claraspital AG   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; JANUS KINASE 2; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMELLIPODIUM; MALE; METASTASIS; METASTASIS POTENTIAL; MICROTUBULE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STRESS FIBER; TRANSCRIPTION REGULATION;

EID: 44849135184     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.071054     Document Type: Article

References (45)

1. Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M, Patel HR: The metastatic cascade in prostate cancer. Surg Oncol 2006, 15:117-128
2. Ihle JN: The Stat family in cytokine signaling. Curr Opin Cell Biol 2001, 13:211-217
3. Levy DE, Darnell Jr JE: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002, 3:651-662
4. Wen Z, Zhong Z, Darnell Jr JE: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250
5. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R: Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002, 62:6659-6666
6. Campbell CL, Jiang Z, Savarese DM, Savarese TM: Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 2001, 158:25-32
7. Huang HF, Murphy TF, Shu P, Barton AB, Barton BE: Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells. Mol Cancer 2005, 4:2-8
8. Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC: Stat3 activation in prostatic carcinomas. Prostate 2002, 51:241-246
9. Horinaga M, Okita H, Nakashima J, Kanao K, Sakamoto M, Murai M: Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology 2005, 66:671-675
10. Lee SO, Lou W, Hou M, de Miguel F, Gerber L, Gao AC: Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res 2003, 9:370-376
11. Barton BE, Karras JG, Murphy TF, Barton A, Huang H: Signal transducer and activator of transcription (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol Cancer Ther 2004, 3:11-20
12. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB: Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005, 24:3397-3408
13. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S: Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006, 66:3188-3196
14. Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H: Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res 2006, 12:7140-7148
15. Silver DL, Naora H, Liu J, Cheng W, Montell DJ: Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004, 64:3550-3558
16. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M: Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 2002, 168:762-765
17. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T, Sekine I: Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 2005, 58:833-838
18. Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC: Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell 2001, 12:3282-3294
19. Debidda M, Wang L, Zang H, Poli V, Zheng Y: A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem 2005, 280:17275-17285
20. Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC: Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA 2001, 98:9014-9019
21. Pelletier S, Duhamel F, Coulombe P, Popoff MR, Meloche S: Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol 2003, 23:1316-1333
22. Hall A: Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514
23. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X: Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 2006, 172:245-257
24. Saramäki O, Willi N, Bratt O, Gasser TC, Koivisto P, Nupponen NN, Bubendorf L, Visakorpi T: Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am J Pathol 2001, 159:2089-2094
25. Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L: Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer 2005, 113:619-628
26. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H: Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005, 24:746-760
27. Nemeth JA, Harb JF, Barroso Jr U, He Z, Grignon DJ, Cher ML: Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999, 59:1987-1993
28. Timár J, Raso E, Dome B, Li L, Grignon D, Nie D, Honn KV, Hagmann W: Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 2000, 87:37-43
29. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS: RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem 2005, 280:36529-36540
30. Muramaki M, Miyake H, Hara I, Kamidono S: Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model. Int J Oncol 2005, 26:623-628
31. Knox JD, Mack CF, Powell WC, Bowden GT, Nagle RB: Prostate tumor cell invasion: a comparison of orthotopic and ectopic models. Invasion Metastasis 1993, 13:325-331
32. Clark J, Edwards S, Feber A, Flohr P, John M, Giddings I, Crossland S, Stratton MR, Wooster R, Campbell C, Cooper CS: Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 2003, 22:1247-1252
33. Yamazaki D, Kurisu S, Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005, 96:379-386
34. Etienne-Manneville S: Actin and microtubules in cell motility: which one is in control? Traffic 2004, 5:470-477
35. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL: Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000, 290:144-147
36. Jaffe AB, Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005, 21:247-269
37. Spiotto MT, Chung TD: STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate 2000, 42:88-98
38. Spiotto MT, Chung TD: STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells. Prostate 2000, 42:186-195
39. Steiner MS: Role of peptide growth factors in the prostate: a review. Urology 1993, 42:99-110
40. Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z: Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Prostate 2005, 64:209-216
41. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005, 365:1054-1061
42. Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, Baffoe-Bonnie A, Jones M, Gildea D, Riedesel E, Albertus J, Isaacs SD, Wiley KE, Mohai CE, Matikainen MP, Tammela TL, Zheng SL, Brown WM, Rokman A, Carpten JD, Meyers DA, Walsh PC, Schleutker J, Gronberg H, Cooney KA, Isaacs WB, Trent JM: Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004, 96:1240-1247
43. Jing N, Sha W, Li Y, Xiong W, Tweardy DJ: Rational drug design of G-quartet DNA as anti-cancer agents. Curr Pharm Des 2005, 11:2841-2854
44. Turkson J, Kim JS, Zhang S, Yuan J, Huang M, Glenn M, Haura E, Sebti S, Hamilton AD, Jove R: Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol Cancer Ther 2004, 3:261-269
45. Song H, Wang R, Wang S, Lin J: A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci USA 2005, 102:4700 -4705 ;